MQS Management LLC Makes New $659,000 Investment in Medtronic PLC $MDT

Posted by Francis Steltz on May 23rd, 2026

MQS Management LLC bought a new position in Medtronic PLC (NYSE:MDT – Free Report) in the fourth quarter, HoldingsChannel.com reports. The fund bought 6,856 shares of the medical technology company’s stock, valued at approximately $659,000.

A number of other institutional investors also recently modified their holdings of the stock. Brighton Jones LLC raised its stake in shares of Medtronic by 1,368.0% during the fourth quarter. Brighton Jones LLC now owns 39,989 shares of the medical technology company’s stock worth $3,194,000 after buying an additional 37,265 shares during the last quarter. Sivia Capital Partners LLC lifted its holdings in Medtronic by 9.6% in the second quarter. Sivia Capital Partners LLC now owns 4,356 shares of the medical technology company’s stock valued at $380,000 after buying an additional 381 shares during the period. Jump Financial LLC acquired a new position in Medtronic in the second quarter valued at approximately $299,000. Main Street Financial Solutions LLC lifted its holdings in Medtronic by 28.9% in the second quarter. Main Street Financial Solutions LLC now owns 14,356 shares of the medical technology company’s stock valued at $1,251,000 after buying an additional 3,218 shares during the period. Finally, HUB Investment Partners LLC lifted its holdings in Medtronic by 21.3% in the second quarter. HUB Investment Partners LLC now owns 19,226 shares of the medical technology company’s stock valued at $1,676,000 after buying an additional 3,376 shares during the period. 82.06% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on MDT. Piper Sandler cut their price objective on shares of Medtronic from $105.00 to $91.00 and set a “neutral” rating on the stock in a report on Wednesday, April 1st. Citigroup cut their price objective on shares of Medtronic from $117.00 to $110.00 and set a “buy” rating on the stock in a report on Tuesday, April 7th. Argus cut their price objective on shares of Medtronic from $125.00 to $115.00 and set a “buy” rating on the stock in a report on Monday, April 6th. Barclays increased their price objective on shares of Medtronic from $118.00 to $120.00 and gave the company an “overweight” rating in a report on Wednesday, April 1st. Finally, UBS Group cut their price objective on shares of Medtronic from $104.00 to $90.00 and set a “neutral” rating on the stock in a report on Wednesday, April 22nd. Fifteen investment analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $106.45.

Get Our Latest Stock Report on Medtronic

Medtronic Stock Up 0.7%

Shares of NYSE MDT opened at $78.66 on Friday. The stock has a market cap of $100.99 billion, a P/E ratio of 21.91, a P/E/G ratio of 1.86 and a beta of 0.62. The firm has a 50 day moving average price of $83.50 and a 200 day moving average price of $93.15. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.87 and a current ratio of 2.54. Medtronic PLC has a 52-week low of $74.40 and a 52-week high of $106.33.

Medtronic (NYSE:MDT – Get Free Report) last issued its quarterly earnings data on Tuesday, February 17th. The medical technology company reported $1.36 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.34 by $0.02. The firm had revenue of $9.02 billion during the quarter, compared to analysts’ expectations of $8.89 billion. Medtronic had a net margin of 13.00% and a return on equity of 14.82%. The business’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.38 earnings per share. Analysts expect that Medtronic PLC will post 5.56 EPS for the current year.

Medtronic Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, April 17th. Stockholders of record on Friday, March 27th were issued a $0.71 dividend. This represents a $2.84 annualized dividend and a dividend yield of 3.6%. The ex-dividend date was Friday, March 27th. Medtronic’s dividend payout ratio is 79.11%.

Medtronic Profile

(Free Report)

Medtronic plc is a global medical technology company that develops and manufactures a broad range of therapeutic devices and health care solutions. Headquartered legally in Ireland with principal operational offices in the United States, the company markets products to hospitals, physicians and health systems worldwide and has grown from its founding in 1949 into one of the largest medical-device manufacturers serving global health-care markets.

Medtronic’s offerings span several clinical areas, including cardiac rhythm and heart failure (pacemakers, implantable cardioverter‑defibrillators and related cardiac therapies), minimally invasive and surgical technologies (laparoscopic and advanced energy devices, visualization systems and surgical innovations), restorative therapies (spine and orthopedics, neuromodulation and neurovascular treatments) and diabetes management (insulin-delivery systems and glucose monitoring solutions).